🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/06/2001 | 48,96 | 49,59 | 44,73 | 44,92 | -8,19% | 9,94% | 74.566 |
| 08/06/2001 | 51,32 | 51,32 | 48,92 | 48,92 | -4,60% | 4,67% | 30.991 |
| 07/06/2001 | 50,23 | 52,21 | 50,19 | 51,28 | +1,86% | 4,02% | 27.278 |
| 06/06/2001 | 51,47 | 52,40 | 50,19 | 50,34 | -3,10% | 4,29% | 26.396 |
| 05/06/2001 | 49,71 | 52,40 | 49,71 | 51,95 | +4,75% | 5,42% | 48.090 |
| 04/06/2001 | 50,04 | 50,53 | 48,70 | 49,59 | +0,38% | 3,66% | 32.674 |
| 01/06/2001 | 48,62 | 49,97 | 48,51 | 49,41 | +0,00% | 3,00% | 25.301 |
| 31/05/2001 | 47,91 | 50,01 | 46,82 | 49,41 | +3,21% | 6,64% | 63.078 |
| 30/05/2001 | 47,80 | 48,02 | 46,79 | 47,87 | +0,16% | 2,58% | 29.575 |
| 29/05/2001 | 48,25 | 50,16 | 47,69 | 47,80 | -1,92% | 5,12% | 23.297 |
| 25/05/2001 | 50,75 | 51,05 | 48,47 | 48,73 | -4,12% | 5,09% | 36.842 |
| 24/05/2001 | 47,16 | 50,94 | 47,16 | 50,83 | +7,78% | 8,02% | 47.155 |
| 23/05/2001 | 48,70 | 49,56 | 46,79 | 47,16 | -4,76% | 5,69% | 45.258 |
| 22/05/2001 | 48,40 | 50,16 | 48,40 | 49,52 | +2,24% | 3,63% | 112.798 |
| 21/05/2001 | 47,99 | 48,66 | 46,97 | 48,43 | +2,37% | 3,51% | 85.867 |
| 18/05/2001 | 48,66 | 48,77 | 46,41 | 47,31 | -2,84% | 4,85% | 129.202 |
| 17/05/2001 | 48,62 | 48,85 | 47,20 | 48,70 | +0,23% | 3,39% | 122.496 |
| 16/05/2001 | 49,67 | 50,34 | 46,75 | 48,58 | -4,42% | 7,23% | 78.574 |
| 15/05/2001 | 50,53 | 51,24 | 50,12 | 50,83 | -0,80% | 2,22% | 37.537 |
| 14/05/2001 | 51,65 | 51,69 | 48,47 | 51,24 | -0,51% | 6,23% | 68.742 |
| 11/05/2001 | 50,46 | 52,03 | 49,78 | 51,50 | +0,81% | 4,45% | 51.563 |
| 10/05/2001 | 51,50 | 52,55 | 48,70 | 51,09 | -2,15% | 7,49% | 75.688 |
| 09/05/2001 | 48,77 | 52,40 | 48,66 | 52,21 | +3,49% | 7,67% | 106.733 |
| 08/05/2001 | 49,59 | 50,53 | 48,51 | 50,46 | +3,30% | 4,08% | 71.814 |
| 07/05/2001 | 48,66 | 49,71 | 48,10 | 48,85 | +1,32% | 3,31% | 99.092 |
| 04/05/2001 | 44,39 | 48,25 | 43,98 | 48,21 | +6,89% | 9,61% | 68.689 |
| 03/05/2001 | 44,92 | 45,25 | 43,04 | 45,10 | -1,15% | 4,92% | 34.064 |
| 02/05/2001 | 43,16 | 45,81 | 43,16 | 45,63 | +4,19% | 6,16% | 65.509 |
| 01/05/2001 | 43,94 | 43,98 | 42,67 | 43,79 | +0,60% | 2,98% | 25.007 |
| 30/04/2001 | 44,54 | 45,48 | 42,74 | 43,53 | -1,94% | 6,13% | 35.854 |